Effect of surgical staging on 539 patients with borderline ovarian tumors: A Turkish Gynecologic Oncology Group study

Basit Öğe Kaydı
dc.contributor.authorGuvenal, Tevfik
dc.contributor.authorDursun, Polat
dc.contributor.authorHasdemir, Pinar S.
dc.contributor.authorHanhan, Merih
dc.contributor.authorGuven, Suleyman
dc.contributor.authorYetimalar, Hakan
dc.contributor.authorGoksedef, Behice P.
dc.date.accessioned2020-03-26T18:41:39Z
dc.date.available2020-03-26T18:41:39Z
dc.date.issued2013
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractObjective. The objectives of this study were to examine demographic and clinicopathologic characteristics and to determine the effects of primary surgery, surgical staging and the extensiveness of staging. Methods. In a retrospective Turkish multicenter study, 539 patients, from 14 institutions, with borderline ovarian tumors were investigated. Some of the demographic, clinical and surgical characteristics of the cases were evaluated. The effects of type of surgery, surgical staging; complete or incomplete staging on survival rates were calculated by using Kaplan-Meier method. Results. The median age at diagnosis was 40 years (range 15-84) and 71.1% of patients were premenopausal. The most common histologic types were serous and mucinous. Majority of the staged cases were in Stage IA (735%). 242 patients underwent conservative surgery. Recurrence rates were significantly higher in conservative surgery group (8.3% vs. 3%). Of all patients in this study, 294 (545%) have undergone surgical staging procedures. Of the patients who underwent surgical staging, 228 (77.6%) had comprehensive staging including lymphadenectomy. Appendectomy was performed on 204 (37.8%) of the patients. The median follow-up time was 36 months (range 1-120 months). Five-year survival rate was 100% and median survival time was 120 months. Surgical staging, lymph node sampling or dissection and appendectomy didn't cause any difference on survival. Conclusion. Comprehensive surgical staging, lymph node sampling or dissection and appendectomy are not beneficial in borderline ovarian tumors surgical management. (C) 2013 Elsevier Inc. All rights reserved.en_US
dc.identifier.doi10.1016/j.ygyno.2013.08.038en_US
dc.identifier.endpage550en_US
dc.identifier.issn0090-8258en_US
dc.identifier.issn1095-6859en_US
dc.identifier.issue3en_US
dc.identifier.pmid24016409en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage546en_US
dc.identifier.urihttps://dx.doi.org/10.1016/j.ygyno.2013.08.038
dc.identifier.urihttps://hdl.handle.net/20.500.12395/29424
dc.identifier.volume131en_US
dc.identifier.wosWOS:000327923400010en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherACADEMIC PRESS INC ELSEVIER SCIENCEen_US
dc.relation.ispartofGYNECOLOGIC ONCOLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectBorderlineen_US
dc.subjectOvarian tumoren_US
dc.subjectLymphadenectomyen_US
dc.subjectAppendectomyen_US
dc.subjectSurgical stagingen_US
dc.titleEffect of surgical staging on 539 patients with borderline ovarian tumors: A Turkish Gynecologic Oncology Group studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu